FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD

We know that, Tiotropium bromide,   is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium bromide capsules for inhalation are co-promoted by Boehringer-Ingelheimand Pfizer under the trade name Spiriva. It is also manufactured and marketed by Cipla under trade name Tiova.

Now Boehringer Ingelheim Pharmaceuticals, Inc. announced  that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily

FDA Approves Spiriva Respimat (tiotropium) for the Maintenance Treatment of COPD